Fleming, Thomas R.
Fleming, Thomas R.
Pole | Ind | Obsah pole |
leader | -----nam-a22------i-4500 | |
1 | xx0135651 | |
3 | CZ PrNK | |
5 | 20220907122604.7 | |
8 | 110503|n|acnnnaabn | a|a | |
40 | ## | $a ABA008 $b cze $d ABA001 |
100 | 1# | $a Fleming, Thomas R. $7 xx0135651 |
400 | 1# | $a Fleming, Thomas Richard $0 o |
667 | $a Záznam neprošel revizí podle pravidel RDA. | |
670 | $a LC (Names) $b autoritní forma | |
670 | $a www(osobní stránka), cit. 9. 8. 2011 $b odkaz viz | |
670 | $a Spellberg, Brad - Fleming, Thomas R. - Gilbert, David N.: Workshop on issues in the design and conduct of clinical trials of antibacterial drugs in the treatment of community-acquired pneumonia, 2008 | |
678 | 0# | $a PhD, americký odborník na biostatistiku (University of Washington, Seattle, USA). |
906 | $a za20110503 $b xdapi | |
906 | $a op20110809 $b epol $c Viz - nově; Zdroj - další výskyt | |
1090 | $a 2001/01/08 $c OSD 002/VOD25 | |
1500 | $a 20110809124341.0 |